Bioretec Oy
OMXH:BRETEC
Bioretec Oy
Revenue
Bioretec Oy
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioretec Oy
OMXH:BRETEC
|
Revenue
€4.5m
|
CAGR 3-Years
31%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
R
|
Revenio Group Oyj
OMXH:REG1V
|
Revenue
€103.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
21%
|
|
|
M
|
Modulight Oyj
OMXH:MODU
|
Revenue
€4m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
O
|
Optomed Oyj
OMXH:OPTOMED
|
Revenue
€15m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nexstim Oyj
OMXH:NXTMH
|
Revenue
€8.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
21%
|
CAGR 10-Years
15%
|
|
|
B
|
Biohit Oyj
OMXH:BIOBV
|
Revenue
€14.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
Bioretec Oy
Glance View
Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. The company is headquartered in Tampere, Lansi-Suomen. The company went IPO on 2021-09-28. The firm operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.
See Also
What is Bioretec Oy's Revenue?
Revenue
4.5m
EUR
Based on the financial report for Dec 31, 2024, Bioretec Oy's Revenue amounts to 4.5m EUR.
What is Bioretec Oy's Revenue growth rate?
Revenue CAGR 5Y
21%
Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Bioretec Oy have been 31% over the past three years , 21% over the past five years .
You don't have any saved screeners yet